Clint Eastwood Awarded $6.1M In CBD Lawsuit

Clint Eastwood may have stumbled at the box office with the release of his latest film “Cry Macho,” but the 91-year-old actor/director scored a $6.1 million victory against a Lithuanian cannabidiol (CBD) company that used his name and image in their product marketing without his permission.

What Happened: According to a New York Times report, Eastwood and Garrapata, the company which owns the rights to his likeness, was awarded $6 million in damages, $95,000 to cover legal fees and a permanent injunction against the future use of his name or image by Mediatonas UAB, which published fake interviews with Eastwood that gave the impression he endorsed its CBD and was considering retirement from filmmaking to focus on the CBD industry.

See also: The Cannabis-COVID Connection: What We Know And What We Don't Know

“In truth, Mr. Eastwood has no connection of any kind whatsoever to any CBD products and never gave such an interview,” said the lawsuit, which was filed in Los Angeles federal court in July 2020.

Eastwood’s legal victory was a default judgment because Mediatonas UAB did not respond to a summons issued in March to appear in court to answer the charges.

What Else Happened: Eastwood filed two additional lawsuits in this matter, The first was against three CBD companies — Sera Labs Inc, Greendios and For Our Vets LLC — that he accused of creating the fraudulent interviews and distributing them in spam emails with the subject line: “Clint Eastwood Exposes Shocking Secret Today.”

The second lawsuit was aimed at 10 U.S. companies and individuals he accused of inserting his name in hidden metatags designed to direct online searches to their CBD-related webpages.

See also: 10 Things You Probably Didn't Know About Clint Eastwood

“Like many of his most famous characters, Mr. Eastwood is not afraid to confront wrongdoing and hold accountable those that try to illegally profit off his name or likeness,” Eastwood’s lawsuit stated.

However, Eastwood was unable to get the court to side with him on his claim that the unauthorized use of his name and image accounted for defamation claims.

“It requires additional context to understand what CBD products are and why a person like Clint Eastwood would not endorse a marijuana-based product,” Judge R. Gary Klausner wrote in his ruling, adding that the language used “was not libelous on its face.”

Photo: Clint Eastwood from his 2018 film "The Mule," courtesy of Warner Bros.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsLegalMarketsCBDClint Eastwoodfraudlawsuitmarketing
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.